Phase IIIB randomized study of Lexiva (FPV) [fosamprenavir] boosted with a reduced dose of ritonavir (RTF)

Trial Profile

Phase IIIB randomized study of Lexiva (FPV) [fosamprenavir] boosted with a reduced dose of ritonavir (RTF)

Not stated
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2006

At a glance

  • Drugs Fosamprenavir (Primary) ; Ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top